Older people and harms from medicines: A pharmacy perspective Debra Rowett Director Drug and Therapeutics Information Service Repatriation General Hospital,

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

“ Handle with Care” A GP guide to cancer care for elderly patients.
Walsall Healthcare NHS Trust Medicines Management.
Disease State Management The Pharmacist’s Role
Table 1: Top five examples of PIP according to the STOPP criteria
Patterns of Prescription Drug Use among Older Adults Arlene S. Bierman, MD, MS Ontario Women’s Health Council Chair in Women’s Health Centre for Research.
Copyright © 2015 Cengage Learning® Chapter 27 Drugs and Older Adults.
The Healthy Option Is that the Route to Funding? Sport and Recreation Alliance Annual Conference 4 th May 2011 Dr William Bird MBE GP Intelligent Health.
UMMS CRIT Module II: Drug Therapy in the Elderly Jerry H. Gurwitz, MD Chief, Division of Geriatric Medicine University of Massachusetts Medical School.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Best Practices for Safe Prescribing in Older ED Patients S. Nicole Hastings, M.D., M.H.S. 1.
Clinical Pharmacy Basma Y. Kentab MSc..
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
Drug safety in the elderly EFNS Stockholm 2012 Barbro Westerholm Prof.em, Member of Swedish Parliament.
Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.
Cornwall Hydration Project
Poor adherence to medication results in $300 billion of unnecessary health care (Vlasnik et al. 2005) Medication discontinuation and subsequent failure.
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
Increasing Pharmacists reporting of adverse medication incidents Being Ready for new risks and Opportunities Prepared by Tim Garrett Northern Sydney Central.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Problems of Polypharmacy
Medicines optimisation – a research pharmacist’s perspective Dr David Alldred Senior Lecturer in Pharmacy Practice 23 January 2015Bradford School of Pharmacy1.
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
Dolores Montero Varsow, 7 October 2011 Risk Management Plan and the elderly.- Some thoughts.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Care Experience Breakout Sessions Trudi Marshall
Age Changes By Sue Henderson.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Why Frail Seniors are Important? A Presentation to the NL Public Sector Pensioners’ Association Oct 7 th 2015 Capital Hotel Dr. Roger Butler Associate.
Drug Therapy in the Elderly
Pharmacovigilance WHO definition
POLYPHARMACY AND MEDICINES OPTIMISATION Professor Tony Avery, University of Nottingham, in collaboration with Dr Martin Duerden Dr Rupert Payne 1.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Supporting people with dementia who also have complex physical health conditions Patricia Howie Educational Projects Manager.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
SYDNEY MEDICAL SCHOOL Why too much medicine is a problem for many older people Departments of Aged Care and Clinical Pharmacology, RNSH Northern Clinical.
Resource Review for Teaching Substance Use and Aging Kathleen J. Farkas, PhD Case Western Reserve University, Mandel School of Applied Social Sciences.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
A better way to care Safe and high-quality care for patients with cognitive impairment (dementia and delirium) in hospital Presented by: Mark Howland CNC.
Medicines management in the elderly Trudi McIntosh and Kim Munro School of Pharmacy and Life Sciences RGU.
Medication Management in the Older Patient. Older adults are more likely to have an Adverse Drug Reaction More likely to be on 5 or more medications Hazzard,
Copyright © 2016 by Elsevier, Inc. All rights reserved. Geropharmacology.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Developing and Implementing Intervention Studies Using Geriatric Assessment Supriya Gupta Mohile, M.D., M.S. Assistant Professor of Medicine James Wilmot.
NPS MEDICINEWISE: PROMOTING SAFE USE OF MEDICINES IN OLDER PEOPLE Zain Elgebay Program Officer NPS MedicineWise.
Aging, Health and Mental Health Prepared for distribution by the CSWE Gero-Ed Center.
EVALUATING THE EFFECTIVENESS OF THE AGS UPDATED 2012 BEERS CRITERIA AS AN EDUCATIONAL TOOL IN A FAMILY MEDICINE RESIDENCY TRAINING PROGRAM Eseoghene Abokede.
Why You Should Never Take PLAVIX and NEXIUM Together.
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Grant Macdonald.  Appropriate polypharmacy describes treatment where a patient has multiple morbidities, and/or a complex condition, that is being managed.
Management of Hypertension according to JNC 7
Medication therapy management
A Welsh Overview of Pharmacy and Falls Prevention
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
HOPE: Heart Outcomes Prevention Evaluation study
What’s New in Medication Management: Focus on Older Adults and Caregivers Tuesday, April 30, :00 Noon CDT Mike Varnell, RPh, CSA (214)
Acute Kidney Injury (AKI)
Multimorbidity: prevention and management
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Skills Workshop M1 Aging Week November 2012
Care of Elderly – and measuring renal function!
Cholinesterase Inhibitors: Actions and Uses
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Many post-MI patients are not receiving optimal therapy
POLYPHARMACY.
Presentation transcript:

Older people and harms from medicines: A pharmacy perspective Debra Rowett Director Drug and Therapeutics Information Service Repatriation General Hospital, South Australia

How do we see harms from medicines? From a society’s perspective From a clinician’s perspective From patient’s perspective

How do we see harms from medicines? Adverse or negative consequences associated with medicines have been documented since the earliest of medical writings but a broader societal concern with medicine related problems is more a modern phenomena.

Older Australians at higher risk of Medication Related problems Over 1 in 4 adverse drug events in older people is considered preventable. One in three unplanned hospital admissions for Australians aged over 75 years is related to medicines use; half of these are considered preventable ,000 hospital admissions each year - 500,000 visits to the general practitioner each year - Cost over $1.2 billion More hospitalisations than are due to diabetes, asthma or heart failure Literature Review: Medication Safety in Australia 2013 Roughead and Semple

Maximising Outcomes Minimising Harms There is compelling evidence that medicines have contributed to decreasing symptom burden, health service utilisation and had mortality benefits. However, medicines also cause adverse or negative consequences.

Balance benefit with iatrogenic burden Benefit Iatrogenic Burden Loss of independence Dry mouth constipation haemorrhageRelief of pain Stroke risk reduction

Balance benefit with iatrogenic burden Benefit Iatrogenic Burden Dose, implement falls risk reduction strategies Monitor INR, adjust for renal function Relief of pain Stroke risk reduction

Balance benefit with iatrogenic burden Benefit Iatrogenic Burden Pain relieved Stroke risk reduction Constipation, dry mouth, incontinence, confusion, sedation minimised

Therapeutics Efficacy Safety

Trial design principally to examine efficacy in single conditions – often exclude those with multimorbidity

Maximising outcomes Minimising harm Full safety profile of the drug is not known when a drug enters the market and can change over the lifecycle of the drugs use Measures used to identify adverse effects often limited to what is known, potential versus actual harm

Older people and harms from medicines: A pharmacy perspective Need to take account of patient preferences and choices – what they consider are important adverse effects or outcomes from their medicines

Older people and harms from medicines: A pharmacy perspective Increasing use of medicines Increasing duration of therapy Increasing potential for drug - drug interactions Increasing potential for drug - disease interactions

A new taxonomy for describing and defining adherence to medications. Vrijens B, De Geest S, Hughes DA, et al. Br J Clin Pharmacol May;73(5): Patient medication adherence not always what you think And there may be good reasons

Adverse drug events masquerading as Geriatric syndromes

Recognise when a medicine is prescribed to treat ADRs caused by a current medicine Your examples

Other examples MedicineAdverse drug reaction (ADR) Second medicine prescribed to treat ADR of first medicine Cholinesterase inhibitor IncontinenceAnticholinergics (e.g. oxybutynin) NSAIDsHypertensionAntihypertensives Thiazide diureticsHyperuricaemia, gout Allopurinol or colchicine MetoclopramideSymptoms of parkinsonism Levodopa ACE inhibitorCoughCough suppressant and/or antibiotic AntipsychoticsExtrapyramidal adverse effects Levodopa, anticholinergics NSAIDs non-steroidal anti-inflammatory drugs, ACE angiotensin converting enzyme Kalisch LM, Caughey GE, Roughead EE, Gilbert AL. The prescribing cascade. Aust Prescr 2011;34:162-6.

" ANY NEW SYMPTOM IN AN OLDER PERSON SHOULD BE CONSIDERED A DRUG SIDE EFFECT UNTIL PROVEN OTHERWISE." Avorn J, Shrank WH. Adverse Drug Reactions in Elderly People: A substantial cause of preventable illness. BMJ 2008;336:956-7.

Barriers to stopping medicines in older people

Encourage your patients to have an accurate and up to date medicines list  Includes prescription, over the counter and complementary medicines.  With documented doses, strengths and directions for use.  Download a Medicines List from

Encourage your patients to have an accurate and up to date medicines list  An up to date medicines list can help: identify potential drug-related causes of new symptoms (prevent prescribing cascade), define and eliminate duplication of therapies, highlight drug interactions, identify medicines prescribed by other doctors, save time when managing medicines.

 Studies have shown frail older people may display profound changes in the pharmacokinetics and pharmacodynamics of some medicines compared to robust older people, putting them at risk of medicines- related problems.  McLachlan AJ, et al. Br J Clin Pharmacol 2011;71:

Physiological changes in the elderly PK changes: Absorption, distribution, metabolism, excretion PD changes: Drug receptors, target organ response

Physiological changes impact on PK & PD

Recognise changing health and vulnerability

Symptom cascades Some of these cascades are well recognised such as constipation and opioids, delirium and confusion following opioids, benzodiazepines and antipsychotics and the list goes on…..

Common symptoms Dry mouth It is a common symptom that may be caused by underlying disease, or as a consequence of surgery, radiotherapy for some head and neck cancers, fluid restriction in people with end stage heart failure and many many medicines.

Commonly used medicines for symptoms such as pain, nausea, agitation, delirium, confusion may all contribute to dry mouth. Careful assessment is required to identify reversible causes.

Oral health in Aged Care EBRAC project

Urge Incontinence The prevalence of urinary incontinence in men is about a third that in women until age 80 when rates converge. One survey of frail older community dwelling people found prevalence rates of 52% of women and 49% of men.

Urge Incontinence A recent meta-analysis found that patients with urge incontinence were almost twice as likely to fall as patients without

Anticholinergic action Drugs with similar physiologic actions interfere with the action of acetylcholine at muscarinic receptor sites Atropine-like effects referred to as parasympatholytic, anticholinergic, antimuscarinic

Solomon D et al Arch Intern Med. 2010;170(22):

The Australian Pain Society’s Pain in Residential Aged Care Facilities: Management Strategies. This publication was funded by the Australian Government Department of Health and Ageing, under the National Palliative Care Program. Copies of the kit may download in PDF format:

Solomon D et al Arch Intern Med. 2010;170(22):

SHPA 9th October 2012 Debra Rowett

Roxburgh A et al MJA 2011; 195: 280–284

Need to be alert to adverse drug effects masquerading as geriatric syndromes Geriatric syndromes include delirium, falls, incontinence and frailty, are highly prevalent, multifactorial, and associated with substantial morbidity and poor outcomes.

“The real voyage of discovery consists not in seeking new landscapes, but in having new eyes." - Marcel Proust

Debra Rowett Director Drug and Therapeutics Information Service Repatriation General Hospital, South Australia